ERYTECH Pharma S.A.
Develops red blood cell-based therapies for cancer and orphan diseases.
ERYP | PA
Overview
Corporate Details
- ISIN(s):
- FR0010417360 (+2 more)
- LEI:
- 969500U8ZZCODU8A9374
- Country:
- France
- Address:
- 60 AVENUE ROCKEFELLER, 69008 LYON
- Website:
- https://phaxiam.com/
- Sector:
- Manufacturing
Description
ERYTECH Pharma S.A. is a clinical-stage biopharmaceutical company that develops innovative therapeutics based on its proprietary ERYCAPS platform, which encapsulates drug substances inside red blood cells. This technology is designed to improve the efficacy and safety of treatments by prolonging the drug's circulation time and reducing side effects. The company's primary focus is on developing treatments for severe forms of cancer and orphan diseases. Its lead product candidate, eryaspase, encapsulates the enzyme L-asparaginase to starve cancer cells of essential nutrients, targeting indications such as acute lymphoblastic leukemia and pancreatic cancer.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-09-20 22:05 |
ERYTECH Provides Business Update and Reports Financial Results for the First Ha…
|
English | 398.0 KB | ||
| 2021-09-15 22:05 |
ERYTECH to Host on September 21, 2021 Second Quarter 2021 conference call and B…
|
English | 230.9 KB | ||
| 2021-09-15 22:05 |
ERYTECH tiendra un webcast le 21 septembre 2021 à l’occasion de ses résultats s…
|
French | 220.7 KB | ||
| 2021-09-06 22:05 |
ERYTECH tiendra une présentation à la H.C. Wainwright 23rd Annual Global Invest…
|
French | 315.4 KB | ||
| 2021-09-06 22:05 |
ERYTECH to Present at the H.C. Wainwright 23rd Annual Global Investment Confere…
|
English | 288.1 KB | ||
| 2021-09-03 18:00 |
Information mensuelle relative au nombre total de droits de vote et d’actions …
|
French | 211.9 KB | ||
| 2021-09-03 18:00 |
Monthly information related to total number of voting rights and shares compos…
|
English | 120.4 KB | ||
| 2021-08-24 22:30 |
ERYTECH organise un webinaire, sur eryaspase dans le cancer du pancréas, avec d…
|
French | 266.2 KB | ||
| 2021-08-24 22:30 |
ERYTECH Hosting Key Opinion Leader Webinar on Eryaspase in Pancreatic Cancer
|
English | 255.6 KB | ||
| 2021-08-05 18:00 |
Information mensuelle relative au nombre total de droits de vote et d’actions c…
|
French | 765.6 KB | ||
| 2021-08-05 18:00 |
Monthly information related to total number of voting rights and shares composi…
|
English | 663.4 KB | ||
| 2021-07-27 07:30 |
ERYTECH to Participate in the BTIG Virtual Biotechnology Conference
|
English | 266.4 KB | ||
| 2021-07-27 07:30 |
ERYTECH annonce sa participation à la conférence virtuelle BTIG Biotechnology
|
French | 296.1 KB | ||
| 2021-07-21 22:05 |
ERYTECH confirme son intention de déposer une demande de BLA pour eryaspase dan…
|
French | 266.1 KB | ||
| 2021-07-21 22:05 |
ERYTECH Confirms Plans To Submit BLA for Eryaspase in Hypersensitive ALL Patie…
|
English | 256.3 KB |
Automate Your Workflow. Get a real-time feed of all ERYTECH Pharma S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ERYTECH Pharma S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ERYTECH Pharma S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-06-23 | N/A | Other | Other | 3,697,533 | 2,255,495.13 EUR |
| 2023-06-23 | N/A | Other | Other | 71,839 | 43,821.79 EUR |
| 2023-06-23 | N/A | Other | Other | 54,862 | 33,465.82 EUR |
Peer Companies
